Skip to main content

Table 1 Baseline characteristics of the participants in the intervention (ZemCAD) and control (CAU) groups (n = 141)

From: Effectiveness of a self-management training for patients with chronic and treatment resistant anxiety or depressive disorders on quality of life, symptoms, and empowerment: results of a randomized controlled trial

 

ZemCAD (n = 70)

Control (n = 71)

Gender, n (%)

 Female

46 (65.70)

47 (66.20)

 Male

24 (34.30)

24 (33.80)

Age (years)

 Mean (SD)

47.03 (7.68)

47.87 (8.90)

 Range

28–63

27–63

Education, n (%)

 Low

34 (50.00)

38 (53.50)

 Intermediate

12 (17.60)

16 (22.50)

 High

22 (32.40)

17 (23.90)

Employment, n (%)

 Paid

14 (20.60)

13 (18.30)

 No paid

54 (79.40)

58 (81.70)

Nationality, n (%)

 Dutch

59 (84.30)

59 (83.10)

 Other

11 (15.70)

12 (16.90)

Partner status, n (%)

 Single

26 (37.10)

39 (54.90)

 Living with partner

44 (62.90)

32 (45.10)

Age of first onset, M (SD)

27.57 (12.22)

24.97 (14.07)

Duration of current symptoms (years), M (SD)

3.59 (5.90)

5.99 (8.06)

Diagnosis according to MINIa, n (%)

 Anxiety

12 (17.10)

12 (16.90)

 Depression

16 (22.90)

21 (29.60)

 Both anxiety and depression

29 (41.40)

33 (46.50)

 No current anxiety or depression

13 (18.60)

5 (7.00)

Quality of life (WHOQOL-BREFb), M (SD)

73.49 (15.34)

72.03 (13.11)

Anxiety (BAIc), M (SD)

43.82 (13.57)

45.28 (11.27)

Depression (PHQ-9d), M (SD)

22.51 (6.42)

23.18 (6.58)

Empowerment (NELe), M (SD)

121.88 (20.46)

121.48 (16.57)

  1. aMINI = MINI International Neuropsychiatric Interview
  2. bWHOQOL-BREF World Health Organisation Quality of Life, Brief version
  3. cBAI Beck Anxiety Inventory
  4. dPHQ-9 Patient Health Questionnaire
  5. eNEL Netherlands Empowerment List